-
1
-
-
34548489173
-
Global estimates of prevalence of HCV infection among injecting drug users
-
Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 2007;18:352-358.
-
(2007)
Int J Drug Policy
, vol.18
, pp. 352-358
-
-
Aceijas, C.1
Rhodes, T.2
-
3
-
-
0034622332
-
Prevalence of antibodies to hepatitis B, hepatitis C and HIV among Irish prisoners: Results of a cross-sectional survey
-
Allwright S, Bradley F, Long J, Barry J, Thornton L, Parry J. Prevalence of antibodies to hepatitis B, hepatitis C and HIV among Irish prisoners: Results of a cross-sectional survey. Br Med J 2000;321:78-82.
-
(2000)
Br Med J
, vol.321
, pp. 78-82
-
-
Allwright, S.1
Bradley, F.2
Long, J.3
Barry, J.4
Thornton, L.5
Parry, J.6
-
4
-
-
0031725816
-
Bloodborne viral infection in Irish injecting drug users
-
Smyth R, Keenan E, O' Connor J. Bloodborne viral infection in Irish injecting drug users. Addiction 1998;93:1649-1656.
-
(1998)
Addiction
, vol.93
, pp. 1649-1656
-
-
Smyth, R.1
Keenan, E.2
Connor J, O.'.3
-
6
-
-
2142768286
-
Hepatitis C treatment eligibility in an urban population with and without HIV coinfection
-
Adeyemi OM, Jensen D, Attar B, et al. Hepatitis C treatment eligibility in an urban population with and without HIV coinfection. AIDS Patient Care STDs 2004;18:239-245.
-
(2004)
AIDS Patient Care STDs
, vol.18
, pp. 239-245
-
-
Adeyemi, O.M.1
Jensen, D.2
Attar, B.3
-
7
-
-
33747428796
-
Natural history, treatment and prevention of hepatitis C in injecting drug users: An overview
-
Jager J, Limburg W, Kretzschmar M, Postma M, Wessing L, eds Luxembourg: Office for Official Publications of the European Communities
-
Limburg W. Natural history, treatment and prevention of hepatitis C in injecting drug users: An overview. In: Jager J, Limburg W, Kretzschmar M, Postma M, Wessing L, eds. EMCDDA Monographs: Hepatitis C and Injecting Drug Use: Impact, Costs and Policy Options. Luxembourg: Office for Official Publications of the European Communities, 2004:21-38.
-
(2004)
EMCDDA Monographs: Hepatitis C and Injecting Drug Use: Impact, Costs and Policy Options
, pp. 21-38
-
-
Limburg, W.1
-
8
-
-
20144388125
-
Factors associated with interest in initiating treatment for hepatitis C virus (HCV) infection among young HCV-infected injection drug users
-
Strathdee SA, Latka M, Campbell J, et al. Factors associated with interest in initiating treatment for hepatitis C virus (HCV) infection among young HCV-infected injection drug users. Clin Infect Dis 2005;40(S5):304-312.
-
(2005)
Clin Infect Dis
, vol.40
, Issue.S5
, pp. 304-312
-
-
Strathdee, S.A.1
Latka, M.2
Campbell, J.3
-
9
-
-
14644390424
-
Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia
-
Doab A, Treloar C, Dore GJ. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. Clin Infect Dis 2005;14(S5):313-320.
-
(2005)
Clin Infect Dis
, vol.14
, Issue.S5
, pp. 313-320
-
-
Doab, A.1
Treloar, C.2
Dore, G.J.3
-
10
-
-
34247897359
-
Management of hepatitis C among drug users attending general practice in Ireland: Baseline data from the Dublin Area Hepatitis C in General Practice Initiative
-
Cullen W, Stanley J, Langton D, Kelly Y, Bury G. Management of hepatitis C among drug users attending general practice in Ireland: Baseline data from the Dublin Area Hepatitis C in General Practice Initiative. Eur J Gen Pract 2007;13:5-12.
-
(2007)
Eur J Gen Pract
, vol.13
, pp. 5-12
-
-
Cullen, W.1
Stanley, J.2
Langton, D.3
Kelly, Y.4
Bury, G.5
-
12
-
-
23744484452
-
Barriers to the treatment of hepatitis C: Patient, provider, and system factors
-
Morrill JA, Shrestha M, Grant RW. Barriers to the treatment of hepatitis C: Patient, provider, and system factors. J Gen Intern Med 2005;20:754-758.
-
(2005)
J Gen Intern Med
, vol.20
, pp. 754-758
-
-
Morrill, J.A.1
Shrestha, M.2
Grant, R.W.3
-
13
-
-
72849123569
-
Hepatitis C Virus is infrequently evaluated and treated in an urban HIV clinic population
-
Scott JD, Wald A, Kitahata M, et al. Hepatitis C Virus is infrequently evaluated and treated in an urban HIV clinic population. AIDS Patient Care STDs 2009;23:925-929.
-
(2009)
AIDS Patient Care STDs
, vol.23
, pp. 925-929
-
-
Scott, J.D.1
Wald, A.2
Kitahata, M.3
-
14
-
-
37049001443
-
Barriers associated with the treatment of hepatitis C virus infection among illicit drug users
-
Grebely J, Genoway KA, Raffa JD, et al. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. Drug Alcohol Depend 2008;93: 141-147.
-
(2008)
Drug Alcohol Depend
, vol.93
, pp. 141-147
-
-
Grebely, J.1
Genoway, K.A.2
Raffa, J.D.3
-
15
-
-
0035253612
-
Hepatitis C disease among injection drug users: Knowledge, perceived risk and willingness to receive treatment
-
Stein MD, Maksad G, Clarke J. Hepatitis C disease among injection drug users: Knowledge, perceived risk and willingness to receive treatment. Drug Alcohol Depend 2001;61:211-215.
-
(2001)
Drug Alcohol Depend
, vol.61
, pp. 211-215
-
-
Stein, M.D.1
Maksad, G.2
Clarke, J.3
-
16
-
-
38149032629
-
A qualitative study among injection drug using women in Rhode Island: Attitudes toward testing, treatment, and vaccination for hepatitis and HIV
-
Lally MA, Monstream-Quas SA, Tanaka S, Tedeschi SK, Morrow KM. A qualitative study among injection drug using women in Rhode Island: Attitudes toward testing, treatment, and vaccination for hepatitis and HIV. AIDS Patient Care STDs 2008;22:53-63.
-
(2008)
AIDS Patient Care STDs
, vol.22
, pp. 53-63
-
-
Ma, L.1
Monstream-Quas, S.A.2
Tanaka, S.3
Tedeschi, S.K.4
Morrow, K.M.5
-
21
-
-
52649147608
-
Critically appraising qualitative research
-
Kuper A, Lingard L, Levinson W. Critically appraising qualitative research. Br Med J 2008;337:687-689.
-
(2008)
Br Med J
, vol.337
, pp. 687-689
-
-
Kuper, A.1
Lingard, L.2
Levinson, W.3
-
22
-
-
51249109876
-
The social production of hepatitis C risk among injecting drug users: A qualitative synthesis
-
Rhodes T, Treloar C. The social production of hepatitis C risk among injecting drug users: A qualitative synthesis. Addiction 2008;103:1593-1603.
-
(2008)
Addiction
, vol.103
, pp. 1593-1603
-
-
Rhodes, T.1
Treloar, C.2
-
23
-
-
33846687361
-
Chronic illness experiences, clinical markers and living with hepatitis C
-
Sutton R, Treloar C. Chronic illness experiences, clinical markers and living with hepatitis C. J Health Psychol 2007;12:330-340.
-
(2007)
J Health Psychol
, vol.12
, pp. 330-340
-
-
Sutton, R.1
Treloar, C.2
-
24
-
-
0036723341
-
Pattern and process in disclosure of health status by women with iatrogenically acquired hepatitis C
-
Dunne E, Quayle E. Pattern and process in disclosure of health status by women with iatrogenically acquired hepatitis C. J Health Psychol 2002;7:565-582.
-
(2002)
J Health Psychol
, vol.7
, pp. 565-582
-
-
Dunne, E.1
Quayle, E.2
-
25
-
-
60249099541
-
Barriers and facilitators related to mammography use among lower educated Mexican women in the USA
-
Tejeda S, Thompson B, Coronado GD, Martin DP. Barriers and facilitators related to mammography use among lower educated Mexican women in the USA. Soc Sci Med 2009; 68:832-839.
-
(2009)
Soc Sci Med
, vol.68
, pp. 832-839
-
-
Tejeda, S.1
Thompson, B.2
Coronado, G.D.3
Martin, D.P.4
-
26
-
-
0034568364
-
Audit of blood-borne virus infections in injecting drug users in general practice
-
Peat M, Budd J, Burns SM, Roberston R. Audit of blood-borne virus infections in injecting drug users in general practice. Comm Dis Public Health 2000;3:244-246.
-
(2000)
Comm Dis Public Health
, vol.3
, pp. 244-246
-
-
Peat, M.1
Budd, J.2
Burns, S.M.3
Roberston, R.4
|